![Alexander Vos](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alexander Vos
Direktor/Vorstandsmitglied bei
ALPHA TEKNOVA, INC.
Vermögen: 260 129 $ am 31.05.2026
Profil
Alexander Vos is currently Chairman at Scenic Biotech BV; Independent Director at Alpha Teknova, Inc. since 2021; Director at InnoCore Technologies BV; Director at Roslin Cell Therapies Ltd.; Member of the Supervisory Board at CiMaas BV since 2018; and Venture Partner at Biogeneration Management BV since 2019.
Former roles include Chief Executive Officer at PharmaCell BV from 2009 to 2017; Chief Executive Officer at MediService AG in 2004; Chief Executive Officer at VarmX BV from 2018 to 2021; Chief Executive Officer at VectorY BV from 2021 to 2022; Chairman of the Supervisory Board at Symeres BV from 2018 to 2021; Director at Alliance for Regenerative Medicine from 2015 to 2018; Chief Operating Officer at PAION AG from 2004 to 2013; Director-Business Development at Genzyme Therapeutics Ltd.; Director-Supervisory Board at Medisse BV; and Strategy Consultant at McKinsey & Co., Inc. Education includes undergraduate and graduate degrees from the University of Amsterdam and an MBA from Stanford Graduate School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ALPHA TEKNOVA, INC. 0.09% | 01.06.2026 | 48’172 ( 0.09% ) | 260 129 $ | 31.05.2026 |
Aktive Positionen von Alexander Vos
| Unternehmen | Position | Beginn |
|---|---|---|
| ALPHA TEKNOVA, INC. | Direktor/Vorstandsmitglied | 01.06.2021 |
Roslin Cell Therapies Ltd.
 Roslin Cell Therapies Ltd. BiotechnologyHealth Technology Develops and manufactures cell and gene therapeutics | Direktor/Vorstandsmitglied | - |
InnoCore Technologies BV
 InnoCore Technologies BV Pharmaceuticals: MajorHealth Technology Develops drug delivery technologies | Direktor/Vorstandsmitglied | - |
CiMaas BV
 CiMaas BV BiotechnologyHealth Technology Develops immunotherapy for cancer | Direktor/Vorstandsmitglied | 01.09.2018 |
Biogeneration Management BV
 Biogeneration Management BV Investment ManagersFinance Biogeneration Management invests in companies located in the United States, Netherlands and Europe. The firm targets companies operating in the fields of biotechnology sectors. It provides financing for pre-seed, seed and early stage capital requirements. It also acts as lead investor. | Private Equity Investor | 01.06.2019 |
Scenic Biotech BV
 Scenic Biotech BV Miscellaneous Commercial ServicesCommercial Services Develops therapies for patients using genomics | Vorsitzender | - |
Ehemalige bekannte Positionen von Alexander Vos
| Unternehmen | Position | Ende |
|---|---|---|
VectorY BV
 VectorY BV BiotechnologyHealth Technology Develops vectorized antibody treatments for people with neurodegenerative diseases | Vorstandsvorsitzender | 08.11.2022 |
Varmx BV
 Varmx BV BiotechnologyHealth Technology Develops and manufactures therapeutic proteins to restore hemostasis | Vorstandsvorsitzender | 15.06.2021 |
Symeres BV
 Symeres BV BiotechnologyHealth Technology Operates as a contract research organization for drug discovery and development activities | Vorsitzender | 01.05.2021 |
| ░░░░░░░░ ░░░ ░░░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Alexander Vos
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
33
Beziehungen ersten Grades
18
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 18 |
|---|---|
PAION AG
 PAION AG Pharmaceuticals: MajorHealth Technology Operates as a holding company whose subsidiaries develops and commercializes specialty pharmaceutical products | Health Technology |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
University of Amsterdam
 University of Amsterdam Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PharmaCell BV
 PharmaCell BV BiotechnologyHealth Technology Manufactures cell therapy and regenerative medicine | Health Technology |
Biogeneration Management BV
Biogeneration Management BV Investment ManagersFinance Biogeneration Management invests in companies located in the United States, Netherlands and Europe. The firm targets companies operating in the fields of biotechnology sectors. It provides financing for pre-seed, seed and early stage capital requirements. It also acts as lead investor. | Finance |
MediService AG
 MediService AG Drugstore ChainsRetail Trade Retails pharmaceuticals and provides medical assistance | Retail Trade |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for patients affected by rare and debilitating diseases | Health Technology |
InnoCore Technologies BV
InnoCore Technologies BV Pharmaceuticals: MajorHealth Technology Develops drug delivery technologies | Health Technology |
Alpha Teknova, Inc.
 Alpha Teknova, Inc. Pharmaceuticals: MajorHealth Technology Manufactures therapeutic and diagnostic products | Health Technology |
Medisse BV
 Medisse BV Medical SpecialtiesHealth Technology Develops resorbable medical implants based on a flexible material | Health Technology |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
Stanford Graduate School of Business
 Stanford Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Varmx BV
Varmx BV BiotechnologyHealth Technology Develops and manufactures therapeutic proteins to restore hemostasis | Health Technology |
Scenic Biotech BV
Scenic Biotech BV Miscellaneous Commercial ServicesCommercial Services Develops therapies for patients using genomics | Commercial Services |
CiMaas BV
CiMaas BV BiotechnologyHealth Technology Develops immunotherapy for cancer | Health Technology |
Roslin Cell Therapies Ltd.
Roslin Cell Therapies Ltd. BiotechnologyHealth Technology Develops and manufactures cell and gene therapeutics | Health Technology |
Symeres BV
Symeres BV BiotechnologyHealth Technology Operates as a contract research organization for drug discovery and development activities | Health Technology |
VectorY BV
VectorY BV BiotechnologyHealth Technology Develops vectorized antibody treatments for people with neurodegenerative diseases | Health Technology |
